Smith & Nephew Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Kingston upon Hull United Kingdom (1856)
Status: No NME R&D (1856)

Organization Overview

First Clinical Trial
2012
NCT01656889
First NDA Approval
1997
becaplermin (regranex)
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

SMITH AND NEPHEW | Smith and Nephew Biotherapeutics | Smith & Nephew Biotherapeutics; Chief Medical Officer | Smith & Nephew, Inc.